Previous close | 0.1850 |
Open | 0.2000 |
Bid | 0.1950 x N/A |
Ask | 0.2100 x N/A |
Day's range | 0.1850 - 0.2000 |
52-week range | 0.1500 - 0.4000 |
Volume | |
Avg. volume | 165,064 |
Market cap | 16.675M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.80 |
Every investor in Cerner Corporation ( NASDAQ:CERN ) should be aware of the most powerful shareholder groups. Generally...
(Bloomberg) -- Oracle Corp. agreed to acquire medical-records systems provider Cerner Corp. for about $28.3 billion, a deal that would add a broad customer base in the health care industry to bolster the software maker’s cloud-computing and database businesses.Most Read from BloombergOmicron May Double Risk of Getting Infected on Planes, IATA SaysOmicron Has 80% Lower Risk of Hospitalization in South AfricaThree Sinovac Doses Fail to Protect Against Omicron in StudyLarry Summers Predicts the Fut
NEW YORK, December 20, 2021--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Cerner Corporation (NASDAQ: CERN) to Oracle Corporation for $95.00 per share is fair to Cerner shareholders.